InsiderTrades.com logo
27 U.S. Cities Where Stocks Yield 26% a Year
From Investing Daily   |   Ad
What’s the highest-yielding stock you’ve ever owned?

The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

GENF Insider Trading

Insider Ownership Percentage: 82.25%
Insider Buying (Last 12 Months): £9,269.97
Insider Selling (Last 12 Months): GBX 0

Genflow Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Genflow Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Genflow Biosciences Share Price & Price History

Current Price: GBX 2.30
Price Change: ▼ Price Decrease of -0.05 (-2.13%)
As of 06/2/2023 05:29 PM ET

This chart shows the closing price history over time for GENF up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
27 U.S. Cities Where Stocks Yield 26% a Year
From Investing Daily   |   Ad
What’s the highest-yielding stock you’ve ever owned?

The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

Genflow Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/18/2022Eric LeireInsiderBuy308,999GBX 3£9,269.97
See Full Table
The Ultimate Passive Income Play
From The Oxford Club   |   Ad
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
>>>

SEC Filings (Institutional Ownership Changes) for Genflow Biosciences (LON:GENF)

0.86% of Genflow Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. The company was incorporated in 2021 and is headquartered in London, the United Kingdom.
Read More on Genflow Biosciences

Today's Range

Now: GBX 2.30
Low: 2.30
High: 2.40

50 Day Range

MA: GBX 3.03
Low: 1.56
High: 5.40

52 Week Range

Now: GBX 2.30
Low: 1.43
High: 5.70

Volume

248,808 shs

Average Volume

1,497,019 shs

Market Capitalization

£6.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Genflow Biosciences?

Genflow Biosciences' top insider investors include:
  1. Eric Leire (Insider)
Learn More about top insider investors at Genflow Biosciences.
27 U.S. Cities Where Stocks Yield 26% a Year
From Investing Daily   |   Ad
What’s the highest-yielding stock you’ve ever owned?

The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.